Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

NCT02576561 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus
High-Grade Squamous Intraepithelial Lesions

Interventions

BIOLOGICAL: TVGV-1
BIOLOGICAL: GPI-0100
BIOLOGICAL: Placebo

Sponsor

THEVAX Genetics Vaccine

Collaborators

[object Object]